MDxHealth SA Holds Shareholder Meetings
Ticker: MDXH · Form: 6-K · Filed: Jun 5, 2024 · CIK: 1872529
| Field | Detail |
|---|---|
| Company | Mdxhealth SA (MDXH) |
| Form Type | 6-K |
| Filed Date | Jun 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-update
TL;DR
MDxHealth SA held shareholder meetings on May 30, 2024, to approve resolutions.
AI Summary
MDxHealth SA held its ordinary annual general shareholders' meeting (AGM) and an extraordinary general shareholders' meeting (EGM) on May 30, 2024. The agenda included the approval of several resolutions related to the company's financial statements and other corporate matters.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to vote on key company decisions and approve financial reports.
Risk Assessment
Risk Level: low — This filing is a routine report of shareholder meetings and does not contain significant new financial or operational information.
Key Players & Entities
- MDxHealth SA (company) — Registrant
- May 30, 2024 (date) — Date of shareholder meetings
FAQ
What type of meetings did MDxHealth SA hold on May 30, 2024?
MDxHealth SA held its ordinary annual general shareholders' meeting (AGM) and an extraordinary general shareholders' meeting (EGM).
What was the primary purpose of the shareholder meetings?
The meetings were held for the approval of a number of resolutions relating to the company's financial statements and other corporate matters.
Is MDxHealth SA required to file annual reports on Form 20-F or 40-F?
MDxHealth SA indicated that it files annual reports under cover of Form 20-F.
What is the principal executive office address of MDxHealth SA?
The principal executive office is located at CAP Business Center Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium.
What is the Commission File Number for MDxHealth SA?
The Commission File Number for MDxHealth SA is 001-40996.
Filing Stats: 605 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2024-06-05 17:02:26
Filing Documents
- ea0207370-6k_mdxhealth.htm (6-K) — 14KB
- ea020737001ex99-1_mdxhealth.htm (EX-99.1) — 88KB
- ea020737001ex99-2_mdxhealth.htm (EX-99.2) — 13KB
- ea020737001ex99-3_mdxhealth.htm (EX-99.3) — 25KB
- ea020737001ex99-4_mdxhealth.htm (EX-99.4) — 186KB
- ex99-2_001.jpg (GRAPHIC) — 4KB
- 0001213900-24-050097.txt ( ) — 332KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: June 5, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2